D-cycloserine Reduces Neuropathic Pain Behavior Through Limbic NMDA-mediated Circuitry

Overview

Journal Pain

Specialties Neurology
Psychiatry

Date 2007 Apr 24

PMID 17449176

Citations 55

Authors

Magali Millecamps

Maria V Centeno

Hector H Berra

Charles N Rudick

Simona Lavarello

Tatiana Tkatch

A Vania Apkarian

Affiliations

Soon will be listed here.

Abstract

Human brain imaging studies suggest that chronic neuropathic pain has a strong emotional component that is mediated by medial prefrontal cortex (mPFC) activity; in rodents, the mPFC is involved in emotional and cognitive aspects of behavior, including the extinction of Pavlovian fear conditioning. Together, these findings suggest that the cortex may modulate the memory trace of pain. As D-cycloserine (DCS), a partial agonist of the NMDA receptor, can enhance learning and potentiate the extinction of acquired fear, in the present study we tested its efficacy in neuropathic pain behavior. In rats with spared nerve injury (SNI), repeated daily oral administration of DCS reduced mechanical sensitivity of the injured limb in a dose-dependent manner; this effect continued for weeks after the cessation of DCS treatment. In addition, re-exposure to DCS further enhanced antinociceptive behavior. Repeated oral DCS administration also reduced cancer chemotherapy drug-induced neuropathic pain behavior. Infusions of DCS directly into the mPFC (especially within prelimbic cortex) or the amygdala (but not into thalamus, insula, or occipital cortex) acutely induced antinociception in SNI rats. The antinociceptive effect of intra-mPFC DCS infusions was mimicked by NMDA and glycine, and blocked by HA 966. In the mPFC of SNI rats, NR2B expression was down-regulated; however, this effect was reversed with repeated oral DCS. Lastly, infusions of DCS into mPFC reversed place avoidance behavior induced by mechanical stimulation of the injured paw in SNI rats. These findings indicate that limbic NMDA-mediated circuitry is involved in long-term reduction in neuropathic pain behavior.

Citing Articles

A Neural Circuit From Paraventricular Nucleus of the Thalamus to the Nucleus Accumbens Mediates Inflammatory Pain in Mice.

Liu X, Zhang X, Wang D, Cao Y, Zhang L, Li Z Brain Behav. 2024; 15(1):e70218.

PMID: 39740781 PMC: 11688111. DOI: 10.1002/brb3.70218.

Targeting Prefrontal Cortex Dysfunction in Pain.

Kummer K, Sheets P J Pharmacol Exp Ther. 2024; 389(3):268-276.

PMID: 38702195 PMC: 11125798. DOI: 10.1124/jpet.123.002046.

Effect of electrical and chemical (activation versus inactivation) stimulation of the infralimbic division of the medial prefrontal cortex in rats with chronic neuropathic pain.

Moura-Pacheco T, Martins-Pereira R, Medeiros P, Sbragia L, Leite-Panissi C, Machado H Exp Brain Res. 2023; 241(11-12):2591-2604.

PMID: 37725136 DOI: 10.1007/s00221-023-06657-y.

A randomized pharmacological fMRI trial investigating D-cycloserine and brain plasticity mechanisms in learned pain responses.

Thomaidou M, Blythe J, Veldhuijzen D, Peerdeman K, van Lennep J, Giltay E Sci Rep. 2022; 12(1):19080.

PMID: 36351953 PMC: 9646732. DOI: 10.1038/s41598-022-23769-7.

Zelquistinel Is an Orally Bioavailable Novel NMDA Receptor Allosteric Modulator That Exhibits Rapid and Sustained Antidepressant-Like Effects.

Burgdorf J, Zhang X, Stanton P, Moskal J, Donello J Int J Neuropsychopharmacol. 2022; 25(12):979-991.

PMID: 35882204 PMC: 9743962. DOI: 10.1093/ijnp/pyac043.

References

Gilmartin M, McEchron M . Single neurons in the medial prefrontal cortex of the rat exhibit tonic and phasic coding during trace fear conditioning. Behav Neurosci. 2006; 119(6):1496-510. DOI: 10.1037/0735-7044.119.6.1496. View

Milad M, Quirk G . Neurons in medial prefrontal cortex signal memory for fear extinction. Nature. 2002; 420(6911):70-4. DOI: 10.1038/nature01138. View

Vertes R . Interactions among the medial prefrontal cortex, hippocampus and midline thalamus in emotional and cognitive processing in the rat. Neuroscience. 2006; 142(1):1-20. DOI: 10.1016/j.neuroscience.2006.06.027. View

Baliki M, Chialvo D, Geha P, Levy R, Harden R, Parrish T . Chronic pain and the emotional brain: specific brain activity associated with spontaneous fluctuations of intensity of chronic back pain. J Neurosci. 2006; 26(47):12165-73. PMC: 4177069. DOI: 10.1523/JNEUROSCI.3576-06.2006. View

Wei F, Wang G, Kerchner G, Kim S, Xu H, Chen Z . Genetic enhancement of inflammatory pain by forebrain NR2B overexpression. Nat Neurosci. 2001; 4(2):164-9. DOI: 10.1038/83993. View

Critchley H, Mathias C, Dolan R . Neural activity in the human brain relating to uncertainty and arousal during anticipation. Neuron. 2001; 29(2):537-45. DOI: 10.1016/s0896-6273(01)00225-2. View

Dolan R . Emotion, cognition, and behavior. Science. 2002; 298(5596):1191-4. DOI: 10.1126/science.1076358. View

Myers K, Davis M . Behavioral and neural analysis of extinction. Neuron. 2002; 36(4):567-84. DOI: 10.1016/s0896-6273(02)01064-4. View

Furukawa H, Gouaux E . Mechanisms of activation, inhibition and specificity: crystal structures of the NMDA receptor NR1 ligand-binding core. EMBO J. 2003; 22(12):2873-85. PMC: 162155. DOI: 10.1093/emboj/cdg303. View

10.

Authier N, Gillet J, Fialip J, Eschalier A, Coudore F . An animal model of nociceptive peripheral neuropathy following repeated cisplatin injections. Exp Neurol. 2003; 182(1):12-20. DOI: 10.1016/s0014-4886(03)00003-7. View

11.

Jasmin L, Rabkin S, Granato A, Boudah A, Ohara P . Analgesia and hyperalgesia from GABA-mediated modulation of the cerebral cortex. Nature. 2003; 424(6946):316-20. DOI: 10.1038/nature01808. View

12.

Baliki M, Al-Amin H, Atweh S, Jaber M, Hawwa N, Jabbur S . Attenuation of neuropathic manifestations by local block of the activities of the ventrolateral orbito-frontal area in the rat. Neuroscience. 2003; 120(4):1093-104. DOI: 10.1016/s0306-4522(03)00408-1. View

13.

Corbit L, Balleine B . The role of prelimbic cortex in instrumental conditioning. Behav Brain Res. 2003; 146(1-2):145-57. DOI: 10.1016/j.bbr.2003.09.023. View

14.

Richardson M, Strange B, Dolan R . Encoding of emotional memories depends on amygdala and hippocampus and their interactions. Nat Neurosci. 2004; 7(3):278-85. DOI: 10.1038/nn1190. View

15.

Bayer K, Ahmadi S, Zeilhofer H . Gabapentin may inhibit synaptic transmission in the mouse spinal cord dorsal horn through a preferential block of P/Q-type Ca2+ channels. Neuropharmacology. 2004; 46(5):743-9. DOI: 10.1016/j.neuropharm.2003.11.010. View

16.

Johansen J, Fields H . Glutamatergic activation of anterior cingulate cortex produces an aversive teaching signal. Nat Neurosci. 2004; 7(4):398-403. DOI: 10.1038/nn1207. View

17.

Apkarian A, Sosa Y, Krauss B, Thomas P, Fredrickson B, Levy R . Chronic pain patients are impaired on an emotional decision-making task. Pain. 2004; 108(1-2):129-36. DOI: 10.1016/j.pain.2003.12.015. View

18.

De Vry J, Kuhl E, Franken-Kunkel P, Eckel G . Pharmacological characterization of the chronic constriction injury model of neuropathic pain. Eur J Pharmacol. 2004; 491(2-3):137-48. DOI: 10.1016/j.ejphar.2004.03.051. View

19.

Garry E, Fleetwood-Walker S . Organizing pains. Trends Neurosci. 2004; 27(6):292-4. DOI: 10.1016/j.tins.2004.03.014. View

20.

Hughes R . Responsiveness to brightness change in male and female rats following treatment with the partial agonist of the N-methyl-D-aspartate receptor, D-cycloserine. Behav Brain Res. 2004; 152(2):199-207. DOI: 10.1016/j.bbr.2003.10.028. View